Pepticom
Developer of AI-based technology for the discovery of peptide drug candidates. The platform's technology is an algorithm that assists in protein-protein interface and peptide-protein interface enabling the design of binding peptides, agonists, and antagonists that are intended to block protein-protein interactions. It analyzes the target surface surrounding the desired binding area and then performs a design process…
Funding snapshot
About
Developer of AI-based technology for the discovery of peptide drug candidates. The platform's technology is an algorithm that assists in protein-protein interface and peptide-protein interface enabling the design of binding peptides, agonists, and antagonists that are intended to block protein-protein interactions. It analyzes the target surface surrounding the desired binding area and then performs a design process to provide a peptide library with optimal binding affinity. Founded in 2011, headquartered in Jerusalem, Israel. The company has raised $7.6M at the Series A stage backed by investors including Chartered High Tech, Chartered Group. Operating in Life Sciences > Genomics, HealthTech > Life Sciences Tech.
Business model
Life Sciences Tech > Research & Development > Drug Discovery > Proteomics,
Genomics > Applied Genomics > Clinical Genomics > Therapeutics
Institutional investors
Latest coverage
No articles yet.
Similar startups
Immuneel
Developer of T-cell therapies for the treatment of cancer. It is developing cell therapies by using genetic engineering that modifies healthy immune cells to target cancerous cells.
ImmunoACT
Developer of cell and gene therapies for cancer treatment. It offers a lead product NexCAR19 Talicabtagene autoleucel for B‑cell malignancies such as B‑lymphoma and B‑acute lymphoblastic leukaemia.
HaystackAnalytics
EmbeDL is a provider of an edge AI optimization and deployment platform that streamlines the path from deep learning model development to hardware-ready deployment on embedded systems.
4baseCare
Sitehop is a provider of hardware-enforced network encryption solutions that delivers ultra-low latency, quantum-ready encryption for data-in-motion in critical networks through its SAFE Series product line.